Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients


Creative Commons License

Atabey R. D. , Aladağ N., Sipal A., Akbulut T., Dogan Z., Ozdemir M.

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, vol.68, no.2, pp.176-182, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 68 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.1590/1806-9282.20210887
  • Journal Name: REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Page Numbers: pp.176-182
  • Keywords: COVID-19, Cardiovascular drugs, Potential risk factors, Renal failure, Intubation
  • Van Yüzüncü Yıl University Affiliated: Yes

Abstract

OBJECTIVES: Cardiovascular diseases are also considered to increase the risk of death in COVID-19 patients. However, real-world data concerning the risk factors for death in patients with severe COVID-19 still remain vague. This study aimed to identify the potential risk factors associated with mortality in severe COVID-19 patients.